Incyte Corp. (INCY)
115.30
-1.84
(-1.57%)
USD |
NASDAQ |
Oct 02, 16:00
115.30
0.00 (0.00%)
After-Hours: 20:00
Incyte Price : 115.30 for Oct. 2, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 02, 2026 | 116.76 | 117.19 | 114.57 | 115.30 | 2.170M |
| Oct 01, 2026 | 120.47 | 121.22 | 117.00 | 117.14 | 2.365M |
| Sep 30, 2026 | 123.00 | 124.23 | 121.03 | 121.35 | 1.620M |
| Sep 29, 2026 | 123.67 | 125.47 | 121.89 | 123.20 | 1.719M |
| Sep 28, 2026 | 123.32 | 126.14 | 122.53 | 124.82 | 1.436M |
| Sep 25, 2026 | 125.72 | 126.00 | 123.07 | 123.89 | 1.210M |
| Sep 24, 2026 | 124.79 | 125.55 | 123.03 | 124.44 | 1.405M |
| Sep 23, 2026 | 127.51 | 128.21 | 123.89 | 124.64 | 1.534M |
| Sep 22, 2026 | 124.72 | 127.75 | 124.01 | 126.93 | 1.647M |
| Sep 21, 2026 | 125.00 | 127.41 | 124.19 | 124.65 | 1.271M |
| Sep 18, 2026 | 127.85 | 128.72 | 125.23 | 125.31 | 3.700M |
| Sep 17, 2026 | 125.74 | 127.74 | 125.10 | 127.62 | 1.469M |
| Sep 16, 2026 | 121.48 | 124.96 | 121.48 | 124.75 | 1.347M |
| Sep 15, 2026 | 121.58 | 122.19 | 119.97 | 121.74 | 1.564M |
| Sep 14, 2026 | 122.48 | 123.34 | 121.28 | 122.19 | 1.456M |
| Sep 11, 2026 | 124.35 | 124.35 | 121.42 | 121.47 | 1.425M |
| Sep 10, 2026 | 125.09 | 126.31 | 122.58 | 123.28 | 1.463M |
| Sep 09, 2026 | 125.66 | 127.72 | 123.57 | 126.01 | 1.301M |
| Sep 08, 2026 | 124.10 | 126.40 | 122.22 | 124.40 | 1.283M |
| Sep 04, 2026 | 126.46 | 128.08 | 126.04 | 126.75 | 1.036M |
| Sep 03, 2026 | 129.67 | 130.00 | 126.20 | 128.00 | 910226.0 |
| Sep 02, 2026 | 126.43 | 129.56 | 125.89 | 128.83 | 2.324M |
| Sep 01, 2026 | 124.61 | 125.14 | 122.50 | 125.01 | 1.192M |
| Aug 31, 2026 | 122.66 | 124.00 | 121.61 | 123.22 | 1.483M |
| Aug 28, 2026 | 127.74 | 127.74 | 123.08 | 124.37 | 1.215M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Regeneron Pharmaceuticals, Inc. | 735.20 |
| Mirum Pharmaceuticals, Inc. | 82.93 |
| Vertex Pharmaceuticals, Inc. | 504.73 |
| Alnylam Pharmaceuticals, Inc. | 219.72 |
| AbbVie, Inc. | 262.82 |
Price Related Metrics
| PE Ratio | 14.69 |
| PS Ratio | 4.068 |
| PEG Ratio | 0.1875 |
| Price to Book Value | 3.652 |
| Price to Free Cash Flow | 12.52 |
| Earnings Yield | 6.81% |
| Market Cap | 23.17B |
| PEGY Ratio | 0.1875 |
| Operating PE Ratio | 12.87 |
| Normalized PE Ratio | 14.47 |